Taylor Andrew Lawrence 4
4 · Orchestra BioMed Holdings, Inc. · Filed Apr 4, 2025
Insider Transaction Report
Form 4
Taylor Andrew Lawrence
Chief Financial Officer
Transactions
- Award
Common Stock, par value $0.0001 per share ("Common Stock")
2025-04-04+84,000→ 428,960 total
Footnotes (1)
- [F1]Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest over a three-year period as follows: (i) 33.33% of the shares will vest 24 months after April 4, 2025 (the "Issue Date"), (ii) 33.33% of the shares will vest 30 months after the Issue Date, and (iii) 33.34% of the shares will vest 36 months after the Issue Date, subject to the Reporting Person's continuous service through such dates.